2NCE

Solution Structure of Ca2+-bound C2 domain from Protein Kinase C alpha in the form of complex with V5-pHM peptide

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
2	3D HNCO	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
3	3D HN(CA)CO	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
4	3D HNCACB	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
5	2D 1H-13C HSQC aliphatic	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
6	3D C(CO)NH	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
7	3D H(CCO)NH	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
8	3D HCCH-TOCSY	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
9	3D HCCH-COSY	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
10	3D 1H-15N TOCSY	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
11	2D 1H-13C HSQC aromatic	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
12	3D HCCH-TOCSY aromatic	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
13	3D 1H-15N NOESY	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
14	3D 1H-13C NOESY	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15
15	3D HNHA	2.225 mM CALCIUM ION, 0.89 mM [U-13C; U-15N] C2, 6.7 mM MES, 67 mM potassium chloride, 0.02 % sodium azide, 2 mM pHM peptide	92% H2O/8% D2O	0.076	6.0	ambient	296.15

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500
2	Bruker	AVANCE	800
3	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
DGSA-distance geometry simulated annealing		ARIA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	400
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	ARIA		Linge, O'Donoghue and Nilges
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	collection	TopSpin		Bruker Biospin
4	data analysis	Sparky		Goddard
5	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
6	structural validation	PSVS		Bhattacharya and Montelione
7	data analysis	CcpNMR		CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.